Trial Profile

A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle- Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 14 Nov 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

04 Sep 2020 Results (n=1640) of post-hoc pooled analysis assessing effects of tretinoin 0.05% lotion on patient-reported quality of life in two studies (NCT02932306 & NCT02965456), published in the American Journal of Clinical Dermatology.
01 Mar 2020 Results (n=1640) from two double-blind placebo-controlled 12-week studies (V01-121A301 and V01-121A302) assessing safety and tolerability in subgroups were published in the Journal of Dermatological Treatment
11 Oct 2018 According to a Bausch & Lomb media release, the results were published in Journal of Drugs in Dermatology.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com